News
- Nobilis Therapeutics Announces Completion of Validation Formalities for the EU Patent It Has Licensed from MassGeneral Brigham March 27, 2022
- Nobilis Therapeutics to Present at CONNECTpreneur on THURSDAY, MARCH 31, 2022, 11:00 AM – 1:00 PM EST. March 27, 2022
- Nobilis Therapeutics Receives NIH Award to Study Xenon Inhaler for Rapid Reduction of Opioid Withdrawal Symptoms September 29, 2021
- Nobilis Therapeutics to participate in Biotechgate Digital Partnering event August 30 Aug – 3 Sep, 2021 July 26, 2021
- Nobilis Therapeutics’ treatment approach gets a favorable review from the Journal of Experimental Pharmacology June 14, 2021
Recent Posts
- Nobilis Therapeutics Announces Completion of Validation Formalities for the EU Patent It Has Licensed from MassGeneral Brigham
- Nobilis Therapeutics to Present at CONNECTpreneur on THURSDAY, MARCH 31, 2022, 11:00 AM – 1:00 PM EST.
- Nobilis Therapeutics Receives NIH Award to Study Xenon Inhaler for Rapid Reduction of Opioid Withdrawal Symptoms
- Nobilis Therapeutics to participate in Biotechgate Digital Partnering event August 30 Aug – 3 Sep, 2021
- Nobilis Therapeutics’ treatment approach gets a favorable review from the Journal of Experimental Pharmacology
Archives
- March 2022
- September 2021
- July 2021
- June 2021
- May 2021
- December 2020
- October 2020
- July 2020
- June 2020
- May 2020
- April 2020
- February 2020
- January 2020
- December 2019
- November 2019
- September 2019
- August 2019
- July 2019
- January 2019
- December 2018
- August 2018
- June 2018
- May 2018
- February 2018
- January 2018
- December 2017
- October 2017
- June 2017
- May 2017
- April 2016
- March 2016
- January 2016
Recent Comments